Cargando…
Distinct Plasma Immune Profile in ALS Implicates sTNFR-II in pAMPK/Leptin Homeostasis
Amyotrophic lateral sclerosis (ALS) is a clinically highly heterogeneous disease with a survival rate ranging from months to decades. Evidence suggests that a systemic deregulation of immune response may play a role and affect disease progression. Here, we measured 62 different immune/metabolic medi...
Autores principales: | Picher-Martel, Vincent, Boutej, Hejer, Vézina, Alexandre, Cordeau, Pierre, Kaneb, Hannah, Julien, Jean-Pierre, Genge, Angela, Dupré, Nicolas, Kriz, Jasna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049559/ https://www.ncbi.nlm.nih.gov/pubmed/36982140 http://dx.doi.org/10.3390/ijms24065065 |
Ejemplares similares
-
Induction of autophagy mitigates TDP-43 pathology and translational repression of neurofilament mRNAs in mouse models of ALS/FTD
por: Kumar, Sunny, et al.
Publicado: (2021) -
Transmission of ALS pathogenesis by the cerebrospinal fluid
por: Mishra, Pooja Shree, et al.
Publicado: (2020) -
Circulating cathepsin-S levels correlate with GFR decline and sTNFR1 and sTNFR2 levels in mice and humans
por: Steubl, Dominik, et al.
Publicado: (2017) -
sTNFR-II and sICAM-1 are associated with acute disease and hepatic inflammation in schistosomiasis japonica
por: Ellis, Magda K., et al.
Publicado: (2008) -
Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: a prospective cohort study
por: Anderson, Brian J., et al.
Publicado: (2019)